Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

Share Price is delayed by 15 minutes
Get Live Data
19.44    -0.08 (-0.41%)
Bid:
19.44
Ask:
19.54
Spread: 0.10 (0.514%)
Market Cap: £49.94m
WJG Live PriceLast checked at - London Stock Exchange

Intraday Watkin Jones Share Chart

Confirmation of Board Changes

13 Oct 2021 07:00

RNS Number : 8611O
Watkin Jones plc
13 October 2021
 

 

 

For immediate release

13 October 2021

 

 

Watkin Jones plc

('Watkin Jones' or the 'Group')

 

Confirmation of Board Changes

 

Further to the announcement on 19 July 2021, Watkin Jones plc (AIM:WJG) confirms the following changes to its Board of Directors.

 

Following an orderly handover, Alan Giddins, Non-executive Director, has assumed the role of Chair and Grenville Turner has retired from the Board, both with effect from 12 October 2021.

 

Sarah Sergeant joined the Board on 6 October 2021 as Chief Financial Officer Designate. Phil Byrom, Chief Financial Officer, will step down from the Board after a suitable handover period.

 

For further information:

Watkin Jones plc

 

Richard Simpson, Chief Executive Officer

Tel: +44 (0) 20 3617 4453

Phil Byrom, Chief Financial Officer

www.watkinjonesplc.com

 

 

 

Peel Hunt LLP (Nominated Adviser & Joint Corporate Broker)

 

Tel: +44 (0) 20 7418 8900

Mike Bell / Ed Allsopp

www.peelhunt.com

 

 

 

Jefferies Hoare Govett (Joint Corporate Broker)

 

Tel: +44 (0) 20 7029 8000

Max Jones / Will Soutar

 

www.jefferies.com

 

 

 

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Richard Oldworth

Jamie Hooper / Steph Whitmore

 

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDLLFFFBLFFBQ
Date   Source Headline
3rd Apr 20177:00 amRNSPre-Close Trading Statement
27th Mar 20171:20 pmRNSNotification of Major Interest in Shares
27th Mar 201711:35 amRNSNotification of Major Interest in Shares
24th Mar 201711:00 amRNSDirector Shareholdings
24th Mar 20177:00 amRNSResult of Placing of Shares in Watkin Jones plc
23rd Mar 20174:36 pmRNSPlacing of Shares in Watkin Jones plc
16th Feb 201712:15 pmRNSResult of Annual General Meeting
6th Feb 20177:00 amRNSForward Sale in Bournemouth
24th Jan 20177:00 amRNSAnnual Report and Notice of Annual General Meeting
18th Jan 20177:00 amRNSFull Year Results 2016
22nd Dec 20167:00 amRNSUpdate on Developments
1st Dec 20167:00 amRNSCardiff and Belfast developments forward sold
17th Nov 20167:00 amRNSPre-Close Trading Statement
4th Oct 20167:00 amRNSForward Sale of St. Mungo Avenue, Glasgow
27th Sep 20167:00 amRNSUpdate on developments completed in 2016
22nd Sep 20167:00 amRNSPlanning consent granted for Hunter Street,Chester
13th Sep 20167:00 amRNSPlanning consent granted for site in Newcastle
22nd Jul 201612:45 pmRNSNotification of Major Interest in Shares
11th Jul 20163:15 pmRNSHoldings in Company
29th Jun 20167:00 amRNSPlanning consent granted for Duncan House
27th Jun 20167:00 amRNSDirector Dealing
9th Jun 20167:00 amRNSHalf year results
20th Apr 20167:00 amRNSIssue of Shares
7th Apr 20167:00 amRNSPre-Close Trading Statement
24th Mar 20169:15 amRNSIssue of Shares
23rd Mar 20167:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.